Some preoperative factors affecting the outcome of microdissection testicular sperm extraction (micro-TESE) have been previously evaluated. However, other than Klinefelter syndrome (KS), no other chromosomal anomalies have been discussed in the context of sperm retrieval outcomes. The objective of this study was to describe chromosomal anomalies and their relationship with sperm retrieval outcomes in patients with non-obstructive azoospermia (NOA). Of the 197 NOA patients whose clinical records were retrospectively reviewed, 144 (73.1%) had normal 46,XY karyotype, 40 (20.3%) had KS (47,XXY), and 13 (6.6%) had other chromosomal anomalies (autosomal in seven cases and sex-chromosomal anomalies in six). Of the seven patients with autosomal anomalies, two had the reportedly normal variant 46,XY,inv(9)(p12;q13). Testicular volume and serum hormone levels (luteinizing hormone, folliclestimulating hormone, and total testosterone) of the patients with chromosomal anomalies other than KS were comparable to those of the patients with normal karyotype. The sperm retrieval rate of the patients with 46,XY karyotype, KS, or other chromosomal anomalies were 27.1%, 22.5%, and 15.4%, respectively, with no statistically significant difference. However, among the samples collected from the 13 patients with chromosomal anomalies other than KS, only those from the two patients with the normal variant 46, XY,inv(9)(p12;q13) contained spermatozoa. Among our series of NOA patients, the incidence of autosomal anomalies was higher than that generally noted among neonates, which suggests that not only sex-chromosomal anomalies but also autosomal anomalies may affect the development of NOA. Furthermore, our findings suggest that sperm retrieval outcome is more unfavorable in NOA patients with chromosomal anomalies than in NOA patients with 46,XY karyotype or KS, despite the use of micro-TESE.
INTRODUCTION
Infertility is defined as a couple's failure to conceive after attempting to conceive for 1 year. Approximately 15% of couples are infertile, and among these couples, male infertility accounts for approximately 50%. Up to 10% of the time, male infertility is because of azoospermia or lack of spermatozoa in the ejaculate. Non-obstructive azoospermia (NOA), a condition in which men have impaired sperm production, accounts for approximately 60% of male infertility because of azoospermia. Men with NOA require some form of sperm retrieval procedure in conjunction with intra-cytoplasmic sperm injection to father their own children.
Microdissection testicular sperm extraction (micro-TESE) is a recognized procedure for patients with NOA. As micro-TESE was first described in 1999 (Schlegel, 1999) , some preoperative factors of micro-TESE outcomes have been evaluated. Although testicular volume and serum follicle-stimulating hormone (FSH) levels are good predictors for the outcomes of conventional TESE (Mitchell et al., 2011) , it has been reported that these factors cannot predict micro-TESE outcomes (Tsujimura et al., 2004; Ramasamy et al., 2013) . On the other hand, it has been reported that patients with Klinefelter syndrome (KS) have favorable micro-TESE outcomes (Ramasamy et al., 2009) . However, the relationship between sperm retrieval outcomes and chromosomal anomalies other than KS is unclear. The objective of the present case series report was to describe the relationship between chromosomal anomalies and sperm retrieval outcomes in NOA patients undergoing micro-TESE.
MATERIAL AND METHODS

Patients
The study consisted of a retrospective review of the clinical records of 197 patients with NOA who underwent micro-TESE in Nagoya City University Hospital or its affiliated hospitals between May 2004 and May 2015. The patients' average age was 34.5 AE 5.0 years. Each patient underwent physical examination, semen analysis, and endocrinologic evaluation. Semen analyses were performed on at least two separate occasions for each patient, and the evaluation was performed according to the methods described in the World Health Organization manuals. Endocrinologic evaluation included assays of serum FSH, luteinizing hormone (LH), and total testosterone levels. Chromosomal analyses were performed using peripheral blood lymphocyte cultures, and following the standard protocol of Giemsa banding. Per patient, 20 to 30 metaphases were examined. Band levels 400-500 were analyzed. Additional chromosome banding (other than Giemsa banding) and fluorescent in situ hybridization were performed to analyze mosaicism. Screening for azoospermia factor (AZF) microdeletions was performed only in patients who wished to be screened. After being informed of the costs and benefits of this investigative procedure, 13 (6.6%) of the 197 patients included in the study consented to undergo screening for AZF microdeletions. This study was conducted according to the Declaration of Helsinki and approved by the Institutional Review Board of the hospital. All participants provided written informed consent permitting the use of their tissue samples in this study.
Micro-TESE procedure
The micro-TESE procedure has been described previously (Schlegel, 1999) . We extracted larger individual seminiferous tubules that appeared more opaque than other surrounding tubules under an operating microscope, and cut them into small pieces to release spermatozoa from the tubules. This processed sample was examined for viable spermatozoa. Finally, testicular biopsy was performed.
Statistical analysis
Statistical comparisons of testicular volume, serum hormone levels, sperm retrieval rate (SRR), and Johnsen score among the three groups were performed using the Tukey's test and the chisquare test. The ps < 0.05 were considered to indicate statistical significance.
RESULTS
Of the 197 patients with NOA included in our study, 144 (73.1%) patients had normal (46,XY) karyotype. Of the remaining 53 patients, 40 (20.3%) patients had KS karyotype (47,XXY) and 13 (6.6%) patients had chromosomal anomalies other than KS. Of these 13 patients, seven (3.6% of the entire study sample) and six (3.0% of the entire study sample) patients had autosomal and sex-chromosomal anomalies, respectively. Of the six patients with sex-chromosomal anomalies, three patients had partial deletion of the Y chromosome, two patients had isochromosome of the Y chromosome, and one patient had 45,X/46,XY mosaicism. Deletion of the AZF region was observed in two patients (cases 1 and 2, as listed in Table 1 ), and represented microdeletion of AZFc in both. Of the patients with autosomal anomalies, two patients had inversion, two patients had reciprocal translocation, one patient had terminal deletion, one patient had quadruple repetitive sequence of satellite chromosomes, and one patient had marker chromosomes. Among the 13 patients with chromosomal anomalies other than KS, no intellectual disability or somatic anomalies were noted, and no patient had hypoandrogenemia. The characteristics of these patients, including karyotype, age, average testicular volume, serum hormone levels (luteinizing hormone, follicle-stimulating hormone, and total testosterone), sperm retrieval outcome, and Johnsen's score evaluated by testicular biopsy are listed in Table 1 .
Testicular volume varied significantly among the 13 patients with chromosomal anomalies other than KS, but was comparable to that noted among NOA patients with 46,XY karyotype, and significantly higher than that noted for NOA patients with KS (Table 2) . Similarly, serum gonadotropin levels among the 13 patients with chromosomal anomalies other than KS were comparable to those noted among NOA patients with 46,XY karyotype, but significantly lower than those noted among NOA patients with KS (Table 2) . Among the 13 patients with chromosomal anomalies other than KS, there was no difference in testicular volume or hormone levels between the patients with autosomal anomalies and those with sex-chromosomal anomalies. One patient (case 2 as listed in Table 1 ) had normal gonadotropin levels and normal testicular volume, which suggests a possible diagnosis of obstructive azoospermia; however, the final diagnosis of NOA was established based on the results of genetic testing (AZFc microdeletion) and histological examination.
Among the 13 patients with chromosomal anomalies other than KS, only the two patients with 46,XY, inv(9)(p12;q13) karyotype, which is described as a normal variant, had successful sperm retrieval (i.e., spermatozoa were found in the processed sample). No spermatozoa were found in patients with autosomal or sex-chromosomal anomalies that did not represent normal variant. Overall, the SRR of the 13 patients with chromosomal anomalies other than KS was 15.4%, which is not significantly different from that noted among NOA patients with 46,XY karyotype (27.1%) or among those with KS (22.5%) ( Table 3) .
DISCUSSION
It has been reported that the incidence of chromosomal anomalies in patients with male infertility is 3.6-13.9% (Pandiyan & Jequier, 1996; Foresta et al., 2005) . Other studies reported the incidence of chromosomal anomalies according to semen analysis findings (Van Assche et al., 1996; Vincent et al., 2002) . Taken together, these reports suggest an incidence of chromosomal anomalies of 14.8% among the patients with NOA. In our series of NOA patients, the incidence of chromosomal anomalies was found to be 26.9%. Even when excluding patients with normal variant, the incidence of chromosomal anomalies in our study sample was 25.9%, which is still significantly higher compared to the values reported previously. We believe it is related to the fact that most of our patients were referred to us from other assisted reproductive technology clinics, suggesting that patients with chromosomal anomalies such as KS or other chromosomal anomalies may have preferentially been referred to our hospital. On the other hand, it has been reported that the incidence of chromosomal anomalies in all neonates is 0.56% (Hamerton et al., 1975) . Our findings indicate that the incidence of chromosomal anomalies in patients with NOA is higher than that in neonates. In addition, patients with NOA and chromosomal anomalies might be able to father children using micro-TESE and intra-cytoplasmic sperm injection (Ando et al., 2013) . Because chromosomal anomalies may be inherited, chromosomal screening before micro-TESE and counseling for patients with chromosomal anomalies represent important measures to be applied in the management of NOA patients.
Among patients with chromosomal anomalies other than KS, spermatozoa were found only in two patients with inversion of chromosome 9. Although it has been reported that inv(9) may affect spermatogenesis to some extent (Collodel et al., 2006) , recent consensus refers to inv(9) as a normal variant with no clinical significance (Jeong et al., 2010) . In our series, two azoospermic patients with inv(9)(p12;q13) achieved successful sperm retrieval using micro-TESE, which indicates that inv(9) indeed has no critical effect on spermatogenesis.
The AZF region is located on the Yq11.2, and deletion of the AZF region leads to disturbance of spermatogenesis (Tiepolo & Zuffardi, 1976) . All our patients with Y chromosome anomalies were suspected to have deletion of the AZF region. The AZF region is classified as AZFa, AZFb, and AZFc (Vogt et al., 1996) . Microdeletion of AZFa and AZFb has worse prognosis, with no reports of successful sperm retrieval (Hopps et al., 2003) . On the other hand, it has been reported that men with microdeletions of AZFc have a very good chance of successful micro-TESE (Stahl et al., 2010) . However, no spermatozoa were found in the samples of our two patients with AZFc microdeletion. We believe that this observation is related to the fact that our series included very few patients with AZF microdeletion. It should also be noted that, in our hospital, screening for AZF microdeletions was not performed for all patients, but only for those who wished to undergo the screening test. Of the 13 patients screened, only two exhibited known AZFc microdeletion; however, it is possible that patients with unrecognized AZF microdeletions were categorized into the normal karyotype group.
In most cases of 45,X/46,XY mosaicism, the cause is considered to be loss by non-disjunction of the Y chromosome after normal disomic fertilization. The majority (90%) of patients with 45,X/46,XY mosaicism show a normal male phenotype, while 10% of these patients show a wide spectrum of phenotypes (e.g., Turner syndrome, mixed gonadal genesis, and disorders of sex development) (Telvi et al., 1999) . In our study, one patient had 45,X/46,XY mosaicism and he showed a normal male phenotype. However, while sperm retrieval has been reported in a patient with 45,X/46,XY mosaicism (Ando et al., 2013) , this was not the case with our patient, as spermatozoa were not found in his sample. There was no significant difference among the groups (p = 0.58; chi-square test); KS, Klinefelter syndrome.
In our study, the SRR of patients with normal karyotype or KS were both lower than previously published values. The reason for the low SRR noted in our series is currently unclear. We believe that the fact that, as previously mentioned, most of our patients were referred to us from other infertility clinics accounts for part of the discrepancy, as it is likely that patients with more severe condition were referred to our hospital, and thus preferentially included in our study. However, a more detailed analysis is warranted to clearly identify the cause of the low SRR regardless of the presence of chromosomal anomalies. The most striking finding in our series is that no spermatozoa were retrieved from patients with chromosomal anomalies other than KS that did not represent a normal variant. The exact relationship between male infertility and chromosomal anomalies observed in our series remains unclear. It has been reported that autosomal anomalies are more common in oligozoospermic than in azoospermic patients (Yatsenko et al., 2010) , which suggests that sex-chromosomal anomalies, rather than autosomal anomalies, have more pronounced effect on the development of azoospermia. However, the higher incidence of autosomal anomalies noted in our series compared to the general incidence noted in all neonates indicates that autosomal anomalies may significantly affect the pathophysiology of azoospermia. Taken together with our finding that sperm retrieval outcomes are unfavorable in patients with autosomal anomalies that do not represent a normal variant, these observations suggest that, once an infertile man with autosomal anomaly develops azoospermia, the outcome of his sperm retrieval may be extremely unfavorable despite using micro-TESE.
CONCLUSIONS
We assessed the incidence of chromosomal anomalies and the sperm retrieval outcomes in patients with NOA. Our results suggested that not only sex-chromosomal anomalies but also autosomal anomalies may be related to NOA. Additionally, our results indicated unfavorable sperm retrieval outcomes in patients with NOA and autosomal anomalies that do not represent a normal variant.
